V
Veritas Aortic Solutions
Single implant for treating complex aortic diseases.
About Veritas Aortic Solutions
Veritas Aortic Solutions is a medical-device spinout from inQB8 Medical Technologies developing the Transcatheter Valved Aortic Root Conduit (TVARC) system — a single permanent implant combining a bioprosthetic aortic valve, an ascending aortic graft, and proprietary coronary perfusion ports, delivered via catheter through the femoral artery. The company is targeting non-surgical treatment for complex aortic root and ascending aortic diseases, conditions for which open-heart surgery remains the only approved option and where combined mortality and morbidity rates can reach as high as 65% for acute cases. Veritas completed prototyping, bench testing, and chronic animal studies within inQB8 before spinning out, and is preparing for first-in-human clinical use.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Headquarters
- Costa Mesa, United States
- Employees
- 9
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Cardiology and cardiovascular
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jun 2026 | $12M | $48M | Cedars-Sinai | ↗ |
| CORPORATE SPINOUT✓Other financing | Dec 2025 | $0 | — | inQB8 Medical Technologies | ↗ |
Growth signals
Latest recorded traffic for Veritas Aortic Solutions is 370 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 AndramedMinimally invasive devices for complex vascular interventions. |
Reutlingen, Germany | Acquired | 5 | — | — |
 Encore Medical Inc.Transcatheter devices for heart septal defect closure. |
United States | Operational | |||
 BioXgenECM cardiac patch reducing post-operative surgical complications. |
Tucson, United States | Operational | |||
 Mountain's 11 Innovation StudioRapid MedTech prototype development for early-stage validation. |
Flagstaff, United States | Operational | |||
 EMBOSCIPolymer embolic devices for predictable vessel occlusion. |
— | Operational | |||
 QUT HeartbeatsStudent-led development of a Total Artificial Heart. |
Brisbane, Australia | Operational | |||
 Advanced Interventional Cardiovascular (AIC) SolutionsNovel devices for endovascular and cardiac interventions. |
— | Operational | |||
 Sutra Medical, Inc.Transcatheter hemi-valve for mitral valve disease treatment. |
Lake Forest, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Cedars-Sinai
Series B and later1 investor entered at this stage
inQB8 Medical Technologies
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Veritas Aortic Solutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Veritas Aortic Solutions’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.